M. Schlumberger, Cancer papillaire et??folliculaire de??la??thyro??de, Annales d'Endocrinologie, vol.68, issue.2-3, pp.120-128, 2007.
DOI : 10.1016/j.ando.2007.04.004

R. Siegel, J. Ma, Z. Zou, and A. Jemal, Cancer statistics, 2014, CA: A Cancer Journal for Clinicians, vol.112, issue.suppl 5, pp.9-29, 2014.
DOI : 10.1002/cncr.23228

L. Davies and H. Welch, Current Thyroid Cancer Trends in the United States, JAMA Otolaryngology???Head & Neck Surgery, vol.140, issue.4, pp.317-339, 2014.
DOI : 10.1001/jamaoto.2014.1

X. Sun, S. Sun, N. Guevara, P. Marcy, I. Peyrottes et al., Indications of external beam radiation therapy in non-anaplastic thyroid cancer and impact of innovative radiation techniques, Critical Reviews in Oncology/Hematology, vol.86, issue.1, pp.52-68, 2013.
DOI : 10.1016/j.critrevonc.2012.09.007

P. Perros, K. Boelaert, S. Colley, C. Evans, R. Evans et al., Guidelines for the management of thyroid cancer, Clinical Endocrinology, vol.339, issue.suppl 15, pp.1-122, 2014.
DOI : 10.1136/bmj.b3527

B. Haugen, E. Alexander, K. Bible, G. Doherty, S. Mandel et al., American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer, 1?133. 7. NCCN Clinical Practice Guidelines in Oncology Thyroid Carcinoma Version 2.2017. Available at, 2015.

J. Higgins and S. Green, Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0 [updated Available at: www.cochrane-handbook.org, The Cochrane Collaboration, 2011.

J. Landis and G. Koch, The Measurement of Observer Agreement for Categorical Data, Biometrics, vol.33, issue.1, pp.159-74, 1977.
DOI : 10.2307/2529310

J. Farahati, C. Reiners, M. Stuschke, S. Müller, G. Stüben et al., Differentiated thyroid cancer Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4) Cancer. 1 janv Papillary thyroid carcinoma: prognostic factors and the role of radioiodine and external radiotherapy Value of external irradiation for locally advanced papillary thyroid cancer, ):172?80. 11. Chow S, pp.1006-1018, 1996.

R. Tsang, J. Brierley, W. Simpson, T. Panzarella, M. Gospodarowicz et al., The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma Postoperative irradiation for thyroid cancer, 375?88. 14. Phlips P, pp.399-404, 1993.

D. Schwartz, M. Lobo, K. Ang, W. Morrison, D. Rosenthal et al., Postoperative External Beam Radiotherapy for Differentiated Thyroid Cancer: Outcomes and Morbidity With Conformal Treatment External beam radiotherapy in the management of differentiated thyroid cancer, International Journal of Radiation Oncology*Biology*Physics. juill Clin Oncol (R Coll Radiol). sept, vol.7415, issue.46, pp.337-378, 2003.

T. Kim, K. Chung, Y. Lee, C. Park, E. Lee et al., The effect of external beam radiotherapy volume on locoregional control in patients with locoregionally advanced or recurrent nonanaplastic thyroid cancer, Radiation Oncology, vol.5, issue.1, p.69, 2010.
DOI : 10.1186/1748-717X-5-69

J. Brierley, R. Tsang, T. Panzarella, N. Bana, R. Osborne et al., Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer, 418?27. 20. Chen PV, p.1, 2005.

J. Kwon, H. Wu, Y. Youn, K. Lee, K. Kim et al., Role of adjuvant postoperative external beam radiotherapy for well differentiated thyroid cancer Results of external beam radiotherapy in patients with well differentiated thyroid carcinoma External beam radiotherapy for differentiated thyroid cancer):24?8. 24. O'Connell ME, A'Hern RP, Harmer CL. Results of external beam radiotherapy in differentiated thyroid carcinoma: a retrospective study from the Royal Marsden Hospital Radiotherapy in well-differentiated thyroid cancer: is it underutilized?: Radiotherapy use in thyroid cancer, Radiation Oncology Journal. Jpn J Clin Oncol. août American Journal of Otolaryngology. janv Eur J Cancer. ANZ Journal of Surgery. sept, vol.3127273086, issue.34169, pp.162-22733, 1994.

Y. Wu, J. Yi, D. Luo, H. Yang, D. Li et al., Analysis of the effectiveness of radiotherapy in postoperative residual tumors in patients with thyroid papillary carcinoma], Zhonghua Zhong Liu Za Zhi. oct, vol.37, issue.10, pp.776-785, 2015.

Z. Yang, J. Flores, S. Katz, C. Nathan, V. Mehta et al., Comparison of Survival Outcomes Following Postsurgical Radioactive Iodine Versus External Beam Radiation in Stage IV Differentiated Thyroid Carcinoma Role of External Beam Radiotherapy in Patients With Advanced or Recurrent Nonanaplastic Thyroid Cancer: Memorial Sloan-Kettering Cancer Center Experience, Thyroid. juill International Journal of Radiation Oncology*Biology*Physics. mars, vol.2773, issue.73, pp.795-801, 2009.

M. Azrif, N. Slevin, A. Sykes, R. Swindell, B. Yap et al., Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation Quality of Life Impact of External Beam Radiotherapy for Advanced Thyroid Carcinoma Improvements in target coverage and reduced spinal cord irradiation using intensity-modulated radiotherapy (IMRT) in patients with carcinoma of the thyroid gland Stereotactic body radiotherapy for refractory cervical lymph node recurrence of nonanaplastic thyroid cancer Otolaryngol Head Neck Surg, 105?13. 30. Gal TJ64?9. 31. Nutting CM, pp.173-80, 2001.

J. Kawabe, S. Higashiyama, M. Sougawa, A. Yoshida, K. Kotani et al., Usefulness of Stereotactic Radiotherapy Using CyberKnife for Recurrent Lymph Node Metastasis of Differentiated Thyroid Cancer. Case Rep Indications de la radiothérapie cervicale des cancers de la thyroïde de souche folliculaire : évaluation de la validité d'un score d

C. Endocrinologie, I. Bordeaux, and . Oncopole, Service de médicine nucléaire Service de médicine nucléaire, Centre Jean Perrin, Clermont-Ferrand, France 6. Service d'endocrinologie, CHRU Lille, France 7 Service de médicine nucléaire Service de médecine nucléaire, Centre Fançois Baclesse Service d'endocrinologie, Hôpital Saint Louis Service d'endocrinologie, CHU Nantes, France 12 Service d'oncologie médicale Service de médecine nucléaire, Institut Curie, Saint-Cloud, France 14 Service de radiothérapie, ICO Site René Gauducheau, Saint Herblain, France 15 Service de radiothérapie, Hôpital de La Salpétrière schéma hypo-fractionné (4 x 5 Gy et 10 x 3 Gy), un patient a été traité par radiothérapie stéréotaxique (SBRT) à la dose de 3 x 18 Gy. 3.3 Traitement par RTE cervicale lors de la récidive Cinquante-huit patients de la cohorte dont 27 de sexe masculin (46,6 %) ont été traités par RTE cervicale après chirurgie de rattrapage pour une récidive locorégionale. Le nombre médian de récidive avant le traitement par RTE était de 2 (1 à 6) La majorité des patients présentaient une lésion récidivante réfractaire à l'iode radioactif (77,6 %) Une atteinte ganglionnaire était retrouvée à l'examen anatomo-pathologique chez 87,5 % des patients, une rupture capsulaire étant retrouvée chez 46,7 % d'entre eux. Le ratio moyen du nombre de ganglions positifs, Affiliation : 1. Service de radiothérapie

R. Traitement-par and . Dans-un-contexte-palliatif, Treize patients ont été pris en charge par RTE cervicale dans le cadre d'une prise en charge palliative. L'âge médian des patients été de 84,7 ans. La lésion était réfractaire à l'iode était retrouvé dans 54,5 % des cas et un hypermétabolisme chez 9 patients sur 10 ayant un TEP-FDG disponible. Une atteinte métastatique à distance était présente chez 46,1 % des patients

M. Schlumberger, Cancer papillaire et??folliculaire de??la??thyro??de, Annales d'Endocrinologie, vol.68, issue.2-3, pp.120-128, 2007.
DOI : 10.1016/j.ando.2007.04.004

B. Haugen, E. Alexander, K. Bible, G. Doherty, S. Mandel et al., American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer, Thyroid. janv, vol.26, issue.1, pp.1-133, 2015.

E. Blais, 2017 Indications for external beam radiotherapy in differentiated thyroid carcinoma: a Tuthyref network group consensus, Crit. Review Onc Hem

X. Sun, S. Sun, N. Guevara, P. Marcy, I. Peyrottes et al., Indications of external beam radiation therapy in non-anaplastic thyroid cancer and impact of innovative radiation techniques, Critical Reviews in Oncology/Hematology, vol.86, issue.1, pp.52-68, 2013.
DOI : 10.1016/j.critrevonc.2012.09.007

R. Tuttle, H. Tala, J. Shah, R. Leboeuf, R. Ghossein et al., Estimating Risk of Recurrence in Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation: Using Response to Therapy Variables to Modify the Initial Risk Estimates Predicted by the New American Thyroid Association Staging System, Thyroid, vol.20, issue.12, pp.1341-1350, 2010.
DOI : 10.1089/thy.2010.0178

M. Biermann, M. Pixberg, A. Schuck, A. Heinecke, W. Köpcke et al., Multicenter study differentiated thyroid carcinoma (MSDS) Diminished acceptance of adjuvant external beam radiotherapy, Nuklearmedizin. déc, vol.42, issue.6, pp.244-50, 2003.

S. Chow, S. Yau, C. Kwan, P. Poon, and S. Law, Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition, Endocrine Related Cancer, vol.13, issue.4, pp.1159-72, 2006.
DOI : 10.1677/erc.1.01320

J. Farahati, C. Reiners, M. Stuschke, S. Müller, G. Stüben et al., Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4). Cancer. 1 janv, pp.172-80, 1996.

T. Kim, D. Yang, K. Jung, C. Kim, M. Choi et al., Value of external irradiation for locally advanced papillary thyroid cancer Postoperative irradiation for thyroid cancer, 1006?12. 10. Phlips P, pp.399-404, 1993.

Z. Yang, J. Flores, S. Katz, C. Nathan, and V. Mehta, Comparison of Survival Outcomes Following Postsurgical Radioactive Iodine Versus External Beam Radiation in Stage IV Differentiated Thyroid Carcinoma, Thyroid, vol.27, issue.7, pp.944-52, 2017.
DOI : 10.1089/thy.2016.0650

J. Brierley, R. Tsang, T. Panzarella, and N. Bana, Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years, Clinical Endocrinology, vol.19, issue.4, pp.418-445, 2005.
DOI : 10.1002/(SICI)1097-0142(19960101)77:1<172::AID-CNCR28>3.0.CO;2-1

P. Chen, R. Osborne, E. Ahn, S. Avitia, G. Juillard et al., Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer The role of postoperative external-beam radiotherapy in the management of patients with papillary thyroid cancer invading the trachea, Ear Nose Throat J. juill International Journal of Radiation Oncology*Biology*Physics. juin, vol.8865, issue.142, pp.474-80, 2006.

J. Kwon, H. Wu, Y. Youn, K. Lee, K. Kim et al., Role of adjuvant postoperative external beam radiotherapy for well differentiated thyroid cancer Results of external beam radiotherapy in patients with well differentiated thyroid carcinoma External beam radiotherapy for differentiated thyroid cancer):24?8. 18. O'Connell ME, A'Hern RP, Harmer CL. Results of external beam radiotherapy in differentiated thyroid carcinoma: a retrospective study from the Royal Marsden Hospital Radiotherapy in well-differentiated thyroid cancer: is it underutilized?: Radiotherapy use in thyroid cancer, 733?9. 19. So K, pp.162-16696, 1994.

Y. Wu, J. Yi, D. Luo, H. Yang, D. Li et al., Analysis of the effectiveness of radiotherapy in postoperative residual tumors in patients with thyroid papillary carcinoma] External beam radiotherapy in the management of differentiated thyroid cancer Postoperative External Beam Radiotherapy for Differentiated Thyroid Cancer: Outcomes and Morbidity With Conformal Treatment, ):776?9. 21. Ford D337?41. 22. Schwartz DL, pp.1083-91, 2003.

T. Kim, K. Chung, Y. Lee, C. Park, E. Lee et al., The effect of external beam radiotherapy volume on locoregional control in patients with locoregionally advanced or recurrent nonanaplastic thyroid cancer, Radiation Oncology, vol.5, issue.1, p.69, 2010.
DOI : 10.1186/1748-717X-5-69

M. Azrif, N. Slevin, A. Sykes, R. Swindell, B. Yap et al., Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation):105?13. 25 Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery Stereotactic body radiotherapy for refractory cervical lymph node recurrence of nonanaplastic thyroid cancer, Radiother Oncol. oct Arch Otolaryngol Head Neck Surg. juill Otolaryngol Head Neck Surg. mars, vol.89128142, issue.263, pp.338-381, 2002.

J. Kawabe, S. Higashiyama, M. Sougawa, A. Yoshida, K. Kotani et al., Usefulness of Stereotactic Radiotherapy Using CyberKnife for Recurrent Lymph Node Metastasis of Differentiated Thyroid Cancer, Case Reports in Endocrinology, vol.75, issue.3, p.7956726, 2017.
DOI : 10.1016/j.radonc.2015.02.021